MLKL and cancer: While substitutions at R30 of MLKL have not been reported in ClinVar or the Catalogue of Somatic Mutations in Cancer (COSMIC) [60,61], the R30E mutation was selected as an experimental tool to dissect mechanisms of downstream MLKL signalling.